Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
about
Progress in treatment of ANCA-associated vasculitisInterventions for renal vasculitis in adultsProphylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsIntravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosisIntravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosisInterventions for renal vasculitis in adultsProphylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsWegener's granulomatosis: current and upcoming therapiesStaphylococcus aureus and Wegener's granulomatosis.The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western CountriesRecent advances in anti-neutrophil cytoplasmic antibody-associated vasculitisPathophysiological Relationship between Infections and Systemic VasculitisGlomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodiesCurrent and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)Rare diseases.3: Wegener's granulomatosisPR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2Molecular mimicry in pauci-immune focal necrotizing glomerulonephritisAnti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel VasculitisUpdates in ANCA-associated vasculitisTh2 dominance in nasal mucosa in patients with Wegener's granulomatosisPathophysiology of ANCA-associated small vessel vasculitisPathogenesis of ANCA-associated vasculitisThe immunopathology of ANCA-associated vasculitisWegener's granulomatosis: a model of auto-antibodies in mucosal autoimmunityConditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitidesThe contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitisA case of granulomatosis with polyangiitis complicated by cyclophosphamide toxicity and opportunistic infections: choosing between Scylla and Charybdis.Endoscopic laser surgery for subglottic stenosis in Wegener's granulomatosis.Cyclophosphamide for ocular inflammatory diseasesLow anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure.Interventions for renal vasculitis in adults. A systematic review.Churg-Strauss syndrome.Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow - up in ANCA - associated vasculitis.Pathogenesis of ANCA-associated systemic vasculitis.Management of ANCA-associated vasculitis: Current trends and future prospectsCost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy.Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitisPregnancy in patients with Wegener's granulomatosis: report of five cases in three women.Diagnosis and treatment of cerebral vasculitis.Wegener granulomatosis causing sellar mass, hydrocephalus, and global pituitary failure
P2860
Q21195258-7A4DBFC6-5C3E-4274-AC10-3D2B6DA3D6B0Q24187038-1E42D4DF-8059-4A88-9AFB-50120E771E21Q24193204-71CD4EFD-A2E7-42BC-AE32-FC0DD93CF30EQ24201647-69AA1B1A-8657-48E8-9881-1C92FFAEABE8Q24240077-CE7F2E82-713C-41E5-8132-741860475031Q24242768-3177BCA1-9D37-487B-A7B8-A77F89DF46EEQ24243871-65869486-543A-46FE-B2C1-E8F741CA5220Q24804964-B1C42BA4-8D07-46B5-B177-3B93B195FDEEQ24805982-72A98FC0-87E4-497C-A891-2188777CBCC2Q26740451-5FDF8D4F-3A24-478E-BEEB-FEC947503F19Q26751357-FBB42E37-95D7-46C4-93AB-D7E54304D241Q26799915-A52F140E-ACE2-45AC-A989-5AC66E88CB79Q27021715-526FEC02-A531-4887-841A-E27FB7F406D2Q27025692-E312C24A-99D5-4290-9273-9B2B8F75E03FQ27477902-D6B2AFBD-B9AB-47E7-9ED4-946736A6F960Q27489023-3C2DC6D4-3142-408D-9529-4A64E187553BQ27489747-02B67D71-CEF2-48B2-BD1D-FF6D18B8C15CQ27490357-85458AC1-A8B3-4A70-9AC5-CCBEAD3D37A7Q28069897-682D252D-88EF-4936-AD82-A65D685DE0BFQ28347701-B8844BA1-D5CD-49D6-86C9-33B6CC3453FBQ28383761-3335A3FB-8630-439D-B90A-4CA4EA1B256EQ28390438-95CD637C-03C4-4B36-9640-F7103678AE10Q28391531-91F062A6-90EC-4C72-B661-CFCA1C48A0E7Q28393433-83419B05-5095-41EA-AE04-7F5A926C3BCEQ28393792-8166EAD7-D066-4360-B40F-D28461AA9BD8Q28395851-FE0A6E5B-60BF-45D4-9D5B-3DDF1D2669B0Q30317533-4099D7C4-3AD5-43EA-9555-A3397FCA615DQ33304030-24BC04AB-1502-413F-8597-F86FD875180CQ33517496-A272C93F-F032-4DAE-A67E-1ECD70CFAEC7Q33556028-0995A2FE-A844-4E13-8E73-41A9E44F2E9AQ33614376-FEAB535A-9753-4687-A3FB-259D0A2B295DQ33704289-C6620E6E-A067-4C4E-8B53-7DC409581D04Q33784256-ABB58020-DCB1-436D-BAA9-D79516FF7247Q33843581-5BDF590E-BFE6-4A95-9BB1-ECFE2577C1E0Q33947599-976F91BC-B394-4890-A4A9-B768CC395D80Q34004622-72D1B9C0-2C28-4E80-9685-78F21CAABA0EQ34018969-DC39D40C-B3BD-4AA7-A51A-F2E12627FFA0Q34045848-B8DCB3DC-1972-436D-97AC-DC0049353A0DQ34156332-587BB94E-6830-48EE-8808-F29361876D49Q34186480-A9195165-D750-455C-AE22-92EBEBE3B438
P2860
Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Trimethoprim-sulfamethoxazole ...... imoxazole Wegener Study Group.
@ast
Trimethoprim-sulfamethoxazole ...... imoxazole Wegener Study Group.
@en
type
label
Trimethoprim-sulfamethoxazole ...... imoxazole Wegener Study Group.
@ast
Trimethoprim-sulfamethoxazole ...... imoxazole Wegener Study Group.
@en
prefLabel
Trimethoprim-sulfamethoxazole ...... imoxazole Wegener Study Group.
@ast
Trimethoprim-sulfamethoxazole ...... imoxazole Wegener Study Group.
@en
P2093
P1476
Trimethoprim-sulfamethoxazole ...... imoxazole Wegener Study Group.
@en
P2093
Kallenberg CG
Stegeman CA
Tervaert JW
de Jong PE
P356
10.1056/NEJM199607043350103
P407
P577
1996-07-01T00:00:00Z